Further analysis of the prognostic implication of mRNA levels of MCM family in CRC performed in cBioPortal database revealed that patients with high MCM3 expression had worse DFS/PFS outcome compared with those with low MCM3 expression (P=0.009339, Figure 5B). This evidence concerns the gene MCM3 and colorectal carcinoma.